Atara losses grew in Q2
Atara Biotherapeutics swallowed more losses in the second quarter of 2021, as the early-stage company hopes for good news for its tab-cel therapy in early 2022. Atara, an immunotherapy biotech company based in South San Francisco with some of its major operations in Thousand Oaks, had a net loss of $83.7 million in the second Read More →
PennyMac misses earnings targets
Both segments of PennyMac’s business missed estimates when they announced their second quarter financial earning reports on Aug. 5. PennyMac Financial Services reported net income of $204.2 million, or $2.94 per share on a diluted basis, missing the 3.48 per share estimate predicted by Zacks Consensus Estimates. The Westlake Village-based financial services segment had earnings Read More →
Velocity shares rise after earnings beat
Velocity Financial saw its net income rise in its second quarter financial earnings, beating estimates. The Westlake Village-based mortgage firm had net income of $9.45 million, or 28 cents per share, well above analysts’ estimates of around 15 cents per share. Velocity Financial more than tripled its net income from the same time a year Read More →
Dubroff: Ventura County ballot measure put Houweling’s in the cannabis cat bird seat
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen shrugs off tough quarter, announces plans for new plant in North Carolina
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.